<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00626951</url>
  </required_header>
  <id_info>
    <org_study_id>07208763-1</org_study_id>
    <nct_id>NCT00626951</nct_id>
  </id_info>
  <brief_title>Crossover Study With the ProSeal and Supreme Laryngeal Mask Airway</brief_title>
  <acronym>Supreme</acronym>
  <official_title>The Supreme Laryngeal Mask Airway. A Randomized, Crossover Study With the ProSeal Laryngeal Mask Airway in Paralyzed, Anesthetized Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University Innsbruck</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The LMA Supreme is a new extraglottic airway device which brings together features of the LMA
      ProSeal, Fastrach and Unique. We test the hypothesis that ease of insertion, oropharyngeal
      leak pressure, fiberoptic position and ease of gastric tube placement differ between the LMA
      ProSeal and the LMA Supreme in paralyzed anesthetized patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The LMA Supreme is a new extraglottic airway device which brings together features of both
      the LMA ProSeal (high seal cuff, gastric access and bite block - to facilitate ventilation,
      airway protection and airway obstruction, respectively), the LMA Fastrach (fixed cuve tube
      and guiding handle - to facilitate insertion and fixation) and the LMA Unique (single use -
      prevention of disease transmission). The new features are that the airway tube incorporates a
      drain tube within its lumen to shorten and straighten its path, it is oval-shaped to match
      the shape of the mouth and to reduce rotation in the pharynx, the inner cuff has been
      strengthened to prevent airway obstruction from infolding and epiglottic fins have been added
      to prevent airway obstruction from epiglottic downfolding. In the following randomized,
      crossover study, we test the hypothesis that ease of insertion, oropharyngeal leak pressure,
      fiberoptic position and ease of gastric tube placement differ between the LMA ProSeal and the
      LMA Supreme in paralyzed, anesthetized patients
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oropharyngeal leak pressure</measure>
    <time_frame>5 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ease of insertion</measure>
    <time_frame>1 min</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">94</enrollment>
  <condition>Paralysis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LMA Supreme</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LMA ProSeal</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LMA Supreme</intervention_name>
    <description>Extraglottic airway devices</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LMA ProSeal</intervention_name>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiology physical status grade I-II

          -  Age 18-80 yr

          -  Elective gynecological surgery

          -  Supine position

        Exclusion Criteria:

          -  Known or predicted difficult airway

          -  Body mass index &gt;35 kg m-2

          -  Risk of aspiration
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Keller, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University Innsbruck</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <state>Tyrol</state>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2008</study_first_submitted>
  <study_first_submitted_qc>February 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 29, 2008</study_first_posted>
  <last_update_submitted>June 25, 2008</last_update_submitted>
  <last_update_submitted_qc>June 25, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 3, 2008</last_update_posted>
  <responsible_party>
    <name_title>Christian Keller MD MSc</name_title>
    <organization>Medical University Innsbruck</organization>
  </responsible_party>
  <keyword>LMA Supreme</keyword>
  <keyword>LMA ProSeal</keyword>
  <keyword>Laryngeal mask airway</keyword>
  <keyword>Ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paralysis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

